Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths.
about
Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomesNosocomial bloodstream infection and clinical sepsisEffects of type and level of training on variation in physician knowledge in the use and acquisition of blood cultures: a cross sectional surveyMethicillin-susceptible ST398 Staphylococcus aureus responsible for bloodstream infections: an emerging human-adapted subclone?Trends in mortality from septicaemia and pneumonia with economic development: an age-period-cohort analysisVisual analysis of DNA microarray data for accurate molecular identification of non-albicans Candida isolates from patients with candidemia episodes.Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.Rapid detection of Candida albicans in clinical samples by DNA amplification of common regions from C. albicans-secreted aspartic proteinase genes.Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group.Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicansSafety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients.In vitro resistance to thrombin-induced platelet microbicidal protein among clinical bacteremic isolates of Staphylococcus aureus correlates with an endovascular infectious source.In vitro resistance to thrombin-induced platelet microbicidal protein is associated with enhanced progression and hematogenous dissemination in experimental Staphylococcus aureus infective endocarditis.Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia.Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia.In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteriaEfficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis model.Prospective study of Candida species in patients at a comprehensive cancer centerSafety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study.Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes.Impact of the high-affinity proline permease gene (putP) on the virulence of Staphylococcus aureus in experimental endocarditis.In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidityComparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.The impact of hospital-acquired bloodstream infections.Canadian clinical practice guidelines for invasive candidiasis in adults.IL-12 and related cytokines: function and regulatory implications in Candida albicans infectionCandidemia in Finland, 1995-1999.Nationwide sentinel surveillance of bloodstream Candida infections in 40 tertiary care hospitals in SpainCharacterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood.The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection.LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus.Nosocomial infections in the intensive care unit: Incidence, risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India.Characterization of a mouse-adapted Staphylococcus aureus strain.Effect of statin use on outcomes of adults with candidemia.Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centersIncidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections.Long term trends in the occurrence of nosocomial blood stream infection.What do central venous catheter-associated bloodstream infections have to do with bundles?g.Identification of small molecules that disrupt vacuolar function in the pathogen Candida albicansPrevalence and population structure of Staphylococcus aureus nasal carriage in healthcare workers in a general population. The Tromsø Staph and Skin Study.
P2860
Q22305929-97A7E996-A8E7-4EBB-9F4D-CEF16BCC6E5CQ24600365-3B422CFA-6336-4E90-B5E0-E0F79B7F2E5DQ24814386-B29F253C-1350-4442-9961-3859F150D5CBQ28394496-862C5B13-0C85-4B1A-812E-7AB9682C2BB3Q28728471-7D117146-5B8E-4064-B7B2-62425E791316Q30391760-17FD00A9-1C3A-4BBA-90B2-7073BEF827A3Q33588900-95E567E4-BCA4-4D8A-A1C9-E523D25E37F2Q33655898-66F44201-38CD-4BA4-90A8-D49BCAD26BBDQ33684486-A7753FCB-980E-4AB6-99C4-197777EF4068Q33695613-CC8AAA43-2074-4A5F-80BF-1791A58E7CC3Q33697079-AA13B1B4-1D22-4BCF-9459-ACCA799115AFQ33703254-48CBE3D4-90E4-41EE-8C11-A904EB55C066Q33757081-2849268C-4F71-408D-9061-18CA6FC6C849Q33788390-96F1FD02-5182-4428-98FF-4AD077520E01Q33875365-210A3516-6649-4520-AF21-304973B359D4Q33976715-D17A5E26-9328-444C-ABCA-DB7B11E93EA9Q33981033-4B8F591F-797C-43CE-862E-4F7EDB27B2F9Q33982572-69700063-4677-4A2B-A3E0-C9A20AD0F996Q33983629-8D196FAE-C6D7-47AC-B6A7-6EB4BC343B37Q33988563-3165AE34-CD0E-4C6B-B983-5A3ADB8B552CQ34000298-50BA2105-BFB5-4E32-AB5A-FE48ACB5405EQ34004808-BD6337C1-FCEA-4A67-9748-0F7773EA99A0Q34108880-52BC67AE-5C7F-4BDB-836C-843E95F7AC3CQ34213597-E2EC82AE-850D-44C7-8E96-C737C8CC8882Q34237335-DD5AAE85-A6AC-480F-B6F0-4BF35DE89EE4Q34261517-01C64CE5-DAE8-48E6-A64C-CA9EC92605DDQ34488253-FF708BDD-02A6-45E9-8207-F7F5D8B61470Q34489579-7B71A98A-88A0-4073-8A44-91FDCEC07E03Q34545013-31BCC705-3D85-4B51-9343-5DCC6851FD0AQ34755628-0E600ABB-8C80-4C85-A2A5-956A221F9407Q34922095-5F7DAF47-CCB8-46D0-990D-C21FC4126EA0Q34975569-7C06AB3C-2391-4F14-8BC6-014154F67C80Q34983848-E3C534C4-0B23-4E41-AA02-365CAAA28D1EQ35025431-18882F45-1C3D-4D29-B20F-74CDD9657272Q35073043-11852751-A275-4342-896B-483CF630C58EQ35656865-3A60A17B-1E0D-44B5-B76A-47D14D7A9653Q36170113-A085D697-0942-4946-84E1-ABB5C2599A84Q36171060-4617CEE4-9C3F-46F5-A276-99DA730867EFQ36267368-9F575907-1453-4737-9184-2EE37083B34CQ36455992-016E3D99-EECA-4738-8C89-482AE1DE6F09
P2860
Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Nosocomial bloodstream infecti ...... tion to total hospital deaths.
@ast
Nosocomial bloodstream infecti ...... tion to total hospital deaths.
@en
Nosocomial bloodstream infecti ...... tion to total hospital deaths.
@nl
type
label
Nosocomial bloodstream infecti ...... tion to total hospital deaths.
@ast
Nosocomial bloodstream infecti ...... tion to total hospital deaths.
@en
Nosocomial bloodstream infecti ...... tion to total hospital deaths.
@nl
prefLabel
Nosocomial bloodstream infecti ...... tion to total hospital deaths.
@ast
Nosocomial bloodstream infecti ...... tion to total hospital deaths.
@en
Nosocomial bloodstream infecti ...... tion to total hospital deaths.
@nl
P1476
Nosocomial bloodstream infecti ...... tion to total hospital deaths.
@en
P2093
P304
P356
10.1001/ARCHINTE.155.11.1177
P407
P577
1995-06-01T00:00:00Z